HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.8% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,069,446 shares of the company's stock after acquiring an additional 19,009 shares during the period. HealthEquity comprises about 1.4% of Stephens Investment Management Group LLC's holdings, making the stock its 17th biggest holding. Stephens Investment Management Group LLC owned 1.24% of HealthEquity worth $94,507,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in HQY. Versant Capital Management Inc acquired a new position in HealthEquity during the first quarter worth $28,000. Transce3nd LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $29,000. Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $39,000. Skandinaviska Enskilda Banken AB publ raised its position in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the last quarter. Finally, Whipplewood Advisors LLC raised its position in shares of HealthEquity by 5,060.0% in the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock valued at $68,000 after buying an additional 759 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Trading Down 2.7%

Shares of HQY traded down $2.67 during mid-day trading on Friday, reaching $94.52. The stock had a trading volume of 1,106,970 shares, compared to its average volume of 868,962. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $116.65. The business's fifty day moving average is $100.98 and its 200 day moving average is $98.43. The firm has a market cap of $8.17 billion, a price-to-earnings ratio of 68.99, a P/E/G ratio of 1.45 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter last year, the firm posted $0.80 earnings per share. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently commented on HQY. Bank of America increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Royal Bank Of Canada increased their target price on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Barrington Research increased their target price on shares of HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Finally, JMP Securities increased their target price on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $118.55.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the transaction, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 over the last 90 days. 1.50% of the stock is owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.